Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Efficacy of Welpass/ropivacaine after Robotic Urologic Surgery
KCT0008822Phase 3Recruiting
- Sponsor
- Genewel
- Start
- Sep 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of Welpass, ropivacaine in postoperative pain, sponsored by Genewel. Started Sep 2023; status: recruiting.
02
Drugs
Welpassropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on KCT0008822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008822.